Northwest Biotherapeutics, Inc. (NWBO)
OTCMKTS · Delayed Price · Currency is USD
0.1565
-0.0086 (-5.21%)
At close: Nov 13, 2026
Northwest Biotherapeutics Market Cap
Northwest Biotherapeutics has a market cap or net worth of $279.25 million as of November 13, 2026. It is the 18,433rd most valuable company in the world and the 3,248th biggest in the United States. Its market cap has decreased by 24.16% in one year.
Market Cap
279.25M
Enterprise Value
358.76M
Revenue
2.86M
Global Rank
Country Rank
#3,248 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 10.29M to 279.25M, an increase of 2,613.99%. That is a compound annual growth rate of 14.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 279.25M | -22.08% |
| Dec 31, 2025 | 358.39M | -1.53% |
| Dec 31, 2024 | 363.95M | -55.71% |
| Dec 29, 2023 | 821.84M | -1.00% |
| Dec 30, 2022 | 830.10M | 25.14% |
| Dec 31, 2021 | 663.34M | -47.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 1.23B |
| CytoDyn | 362.97M |
| Glorywin Entertainment Group | 234.77M |
| HST Global | 209.33M |
| Vaxart | 89.61M |
| BetterLife Pharma | 87.20M |
| ProText Mobility | 72.97M |
| Nuo Therapeutics | 52.79M |